Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cardinal Health Inc CAH

Cardinal Health, Inc. is a global healthcare services and products company. The Company is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.


NYSE:CAH - Post by User

Bullboard Posts
Post by swissincon Jun 02, 2003 1:28pm
525 Views
Post# 6135699

Time to load up?

Time to load up?Several factors are contributing to surging utilization that is driving the value of the pharmaceutical market higher,including an aging population base;growth outcomes data documenting the clinical cost of efficacy of pharmaceutical therapy;accelerating development of new drugs,both branded and generic and direct -to- custumer advertising. My thesis remains that numerous drug therapies will be released over the next few years,which will need to be discovered,developed,manufacutured,packaged,distributed and sold.Therapies will need to be linked to diseases and monitored.Drug benefits will need to be coordinated,and perscriptions claims processed.Information on utilization will need to be aggregated and returned to the manufacturers. SwissINC
Bullboard Posts